113
Participants
Start Date
September 10, 2020
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
SPYK04
SPYK04 capsule
Virginia Cancer Specialists, Fairfax
University of Virginia, Charlottesville
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Minnesota Oncology, Minneapolis
Texas Oncology, Tyler
MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Centers, Lone Tree
Arizona Oncology, Tucson
Rhode Island Hospital, Providence
National Cancer Center Hospital East, Kashiwa
Kurume University Hospital, Kurume
National Cancer Center Hospital, Chuo Ku
Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-Ku
National Hospital Organization Kyushu Cancer Center, Fukuoka
Osaka Prefectural Hospital Organization Osaka International Cancer Center, Osaka
Lead Sponsor
Chugai Pharmaceutical
INDUSTRY